Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

EOS imaging lists on NYSE Euronext via IPO

Executive Summary

French orthopedic device company EOS imaging SA (formerly biospace med) raised €37.9mm ($50mm) through its four times oversubscribed initial public offering of 5.52 new shares at €6.87 each. EOS’s shares will trade on the NYSE Euronext in Paris.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
      • X-ray
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies